Influence of Initial Treatment Modality on Long-Term Control of Chronic Idiopathic Urticaria

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Kim, Sujeong ^a   Baek, Seunghee ^b   Shin, Bomi ^a   Yoon, Sun young ^a   Park, So Young ^a   Lee, Taehoon ^a   Lee, Yoon Su ^a   Bae, Yun Jeong ^b   Kwon, Hyouk Soo ^a   Cho, You Sook ^a   Moon, Hee Bom ^a   Kim, Tae Bum ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CORTICOSTEROID;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CHRONIC DRUG ADMINISTRATION; CHRONIC URTICARIA; CLINICAL EVALUATION; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; DISEASE CONTROL; DISEASE DURATION; DISEASE EXACERBATION; DRUG EFFICACY; FATIGUE; FEMALE; FOOD ALLERGY; HUMAN; IDIOPATHIC DISEASE; KOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MONOTHERAPY; PHYSICAL STRESS; PROPENSITY SCORE; SEX DIFFERENCE; SURVIVAL RATE; TERTIARY HEALTH CARE;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ADULT; CHRONIC DISEASE; DEMOGRAPHY; DRUG PRESCRIPTIONS; DRUG THERAPY, COMBINATION; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PHYSICIAN'S PRACTICE PATTERNS; PROPORTIONAL HAZARDS MODELS; URTICARIA;

EID: 84880706279     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069345     Document Type: Article

References (31)

1. Greaves M, (2000) Chronic urticaria. J Allergy Clin Immunol 105: 664-672.
2. Maurer M, Weller K, Bindslev-Jensen C, Gimenez-Arnau A, Bousquet PJ, et al. (2011) Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report. Allergy 66: 317-330.
3. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW, (1997) The impact of chronic urticaria on the quality of life. Br J Dermatol 136: 197-201.
4. Kozel MM, Mekkes JR, Bossuyt PM, Bos JD, (2001) Natural course of physical and chronic urticaria and angioedema in 220 patients. J Am Acad Dermatol 45: 387-391.
5. Kulthanan K, Jiamton S, Thumpimukvatana N, Pinkaew S, (2007) Chronic idiopathic urticaria: prevalence and clinical course. J Dermatol 34: 294-301.
6. Sibbald RG, Cheema AS, Lozinski A, Tarlo S, (1991) Chronic urticaria. Evaluation of the role of physical, immunologic, and other contributory factors. Int J Dermatol 30: 381-386.
7. van der Valk PG, Moret G, Kiemeney LA, (2002) The natural history of chronic urticaria and angioedema in patients visiting a tertiary referral centre. Br J Dermatol 146: 110-113.
8. Toubi E, Kessel A, Avshovich N, Bamberger E, Sabo E, et al. (2004) Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients. Allergy 59: 869-873.
9. Młynek A, Magerl M, Hanna M, Lhachimi S, Baiardini I, et al. (2009) The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings. Allergy 64: 927-936.
10. Champion RH, Roberts SO, Carpenter RG, Roger JH, (1969) Urticaria and angio-oedema. A review of 554 patients. Br J Dermatol 81: 588-597.
11. Quaranta JH, Rohr AS, Rachelefsky GS, Siegel SC, Katz RM, et al. (1989) The natural history and response to therapy of chronic urticaria and angioedema. Ann Allergy 62: 421-424.
12. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, et al. (2009) EAACI/GA(2)LEN/EDF/WAO guideline: management of urticaria. Allergy 64: 1427-1443.
13. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, et al. (2009) EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 64: 1417-1426.
14. Maurer M, Mlynek A, Zalewska-Janowska A, Martus P, Staubach P, et al. (2008) How to assess disease activity in patients with chronic urticaria? Allergy 63: 777-780.
15. Heinze G, Juni P (2011) An overview of the objectives of and the approaches to propensity score analyses. Eur Heart J.
16. Austin PC, (2009) The Relative Ability of Different Propensity Score Methods to Balance Measured Covariates Between Treated and Untreated Subjects in Observational Studies. Medical Decision Making 29: 661-677.
17. Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, et al. (2006) Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 163: 262-270.
18. Najib U, Bajwa ZH, Ostro MG, Sheikh J, (2009) A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol 103: 496-501.
19. Irinyi B, Szeles G, Gyimesi E, Tumpek J, Heredi E, et al. (2007) Clinical and laboratory examinations in the subgroups of chronic urticaria. Int Arch Allergy Immunol 144: 217-225.
20. Caproni M, Volpi W, Giomi B, Cardinali C, Antiga E, et al. (2004) Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm Venereol 84: 288-290.
21. Jee Ho Choi HCE, Yoo Shin Lee, (1983) Clinical and Laboratory Study of Chronic Urticaria. The Korean Journal of Dermatology 21: 673-681.
22. Ji Young Lee CWP, Cheol Heon Lee, (2000) Evaluation of Autoimmunity in Patients with Chronic Urticaria. The Korean Journal of Dermatology 38: 221-226.
23. Chung MC, Symons C, Gilliam J, Kaminski ER, (2010) The relationship between posttraumatic stress disorder, psychiatric comorbidity, and personality traits among patients with chronic idiopathic urticaria. Comprehensive Psychiatry 51: 55-63.
24. Chung MC, Symons C, Gilliam J, Kaminski ER, (2010) Stress, psychiatric co-morbidity and coping in patients with chronic idiopathic urticaria. Psychol Health 25: 477-490.
25. Khalaf AT, Liu XM, Sheng WX, Tan JQ, Abdalla AN, (2008) Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticaria. J Eur Acad Dermatol Venereol 22: 487-492.
26. Nettis E, Colanardi MC, Barra L, Ferrannini A, Vacca A, et al. (2006) Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. British Journal of Dermatology 154: 533-538.
27. Kaplan AP, Spector SL, Meeves S, Liao YN, Varghese ST, et al. (2005) Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Annals of Allergy Asthma & Immunology 94: 662-669.
28. Handa S, Dogra S, Kumar B, (2004) Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria. J Dermatolog Treat 15: 55-57.
29. Leynadier F, Duarte-Risselin C, Murrieta M, (2000) Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group. Eur J Dermatol 10: 205-211.
30. Breneman DL, (1996) Cetirizine versus hydroxyzine and placebo in chronic idiopathic urticaria. Ann Pharmacother 30: 1075-1079.
31. Zuberbier T, Ifflander J, Semmler C, Henz BM, (1996) Acute urticaria: Clinical aspects and therapeutic responsiveness. Acta Dermato-Venereologica 76: 295-297.